150 related articles for article (PubMed ID: 1978509)
21. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
22. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
23. Neuromelanin and Parkinson's disease.
Marsden CD
J Neural Transm Suppl; 1983; 19():121-41. PubMed ID: 6321645
[TBL] [Abstract][Full Text] [Related]
24. The nigrostriatal system in Parkinson's disease.
Graybiel AM; Hirsch EC; Agid Y
Adv Neurol; 1990; 53():17-29. PubMed ID: 1978514
[TBL] [Abstract][Full Text] [Related]
25. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases.
Youdim MB; Fridkin M; Zheng H
Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213
[TBL] [Abstract][Full Text] [Related]
26. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease.
de la Monte SM; Wells SE; Hedley-Whyte T; Growdon JH
Ann Neurol; 1989 Sep; 26(3):309-20. PubMed ID: 2802531
[TBL] [Abstract][Full Text] [Related]
27. Amyloid beta-peptide and the dementia of Parkinson's disease.
Jendroska K; Lees AJ; Poewe W; Daniel SE
Mov Disord; 1996 Nov; 11(6):647-53. PubMed ID: 8914090
[TBL] [Abstract][Full Text] [Related]
28. [Parkinson syndrome and cognitive disorders].
Szirmai I; Kovács T
Ideggyogy Sz; 2002 Jul; 55(7-8):220-5. PubMed ID: 12201229
[TBL] [Abstract][Full Text] [Related]
29. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.
Chan-Palay V; Asan E
J Comp Neurol; 1989 Sep; 287(3):373-92. PubMed ID: 2570794
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.
Lowe J; Blanchard A; Morrell K; Lennox G; Reynolds L; Billett M; Landon M; Mayer RJ
J Pathol; 1988 May; 155(1):9-15. PubMed ID: 2837558
[TBL] [Abstract][Full Text] [Related]
31. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
32. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway.
Jellinger KA
Mol Chem Neuropathol; 1991 Jun; 14(3):153-97. PubMed ID: 1958262
[TBL] [Abstract][Full Text] [Related]
33. Neuronal inclusions of Parkinson's disease.
Gibb WR; Scott T; Lees AJ
Mov Disord; 1991; 6(1):2-11. PubMed ID: 1848677
[TBL] [Abstract][Full Text] [Related]
34. Morphological substrates of dementia in parkinsonism. A critical update.
Jellinger KA
J Neural Transm Suppl; 1997; 51():57-82. PubMed ID: 9470129
[TBL] [Abstract][Full Text] [Related]
35. Dementia and Parkinson's disease.
Gibb WR
Br J Psychiatry; 1989 May; 154():596-614. PubMed ID: 2557109
[TBL] [Abstract][Full Text] [Related]
36. Pathological basis for neurotransmitter changes in Parkinson's disease.
Mann DM; Yates PO
Neuropathol Appl Neurobiol; 1983; 9(1):3-19. PubMed ID: 6133229
[TBL] [Abstract][Full Text] [Related]
37. Neuronal filaments in Alzheimer's, Pick's, and Parkinson's diseases.
Kahn J; Anderton BH; Gibb WR; Lees AJ; Wells FR; Marsden CD
N Engl J Med; 1985 Aug; 313(8):520-1. PubMed ID: 4040609
[No Abstract] [Full Text] [Related]
38. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb WR; Lees AJ
J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):745-52. PubMed ID: 2841426
[TBL] [Abstract][Full Text] [Related]
39. Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.
Zgaljardic DJ; Foldi NS; Borod JC
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1287-301. PubMed ID: 15480839
[TBL] [Abstract][Full Text] [Related]
40. [Free radicals and degenerative diseases of the nervous system].
Hirai S; Tanaka M; Sotomatsu A
Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):171-6. PubMed ID: 2200916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
